Periodontal diseases are a group of chronic, progressive bacterial infections resulting in inflammation and destruction of tooth supporting structures that can have significant effects on general health and vice versa.1 Among the common oral conditions the most studied condition is inflammatory periodontal disease, typically in the form of chronic periodontitis, which is considered the second most prevalent oral disease worldwide and is the fourth most frequent illness on the Disease Global Burden list.2 Although the essential etiologic factor responsible for inducing the host inflammatory process is bacterial plaque but it is the host susceptibility and ability of the host defence to respond appropriately to the bacterial confront in periodontal diseases.3 The field of oral-systemic health connections has been a rapidly advancing area of research that has been gaining great interest by scientists and clinicians.4 Moreover, most commonly explored oral- systemic health link is between systemic conditions and periodontal diseases and this relationship is bidirectional, whereby not only systemic health can affect periodontal health but also periodontal disease can affect systemic health.5, 6 Though, the influence of systemic disorders on periodontal diseases is well established but interesting ongoing research is to study the effect of periodontal diseases on numerous systemic diseases or conditions, like cardiovascular disease, diabetes, adverse pregnancy outcomes, respiratory diseases, respiratory and others including osteoporosis, cancer, rheumatoid arthritis, Alzheimer's disease, gastrointestinal disease and chronic kidney diseases.3, 7, 8, 9 This emerging side of the oral-systemic link has been termed Periodontal Medicine. Periodontal medicine is a term used to describe how periodontal infection/inflammation may affect systemic health. Recent systematic review of clinical trials on periodontal medicine indicated that periodontal medicine is a very active field in periodontology and various systemic conditions have been hypothesized to be linked with periodontal diseases, thereby suggesting the possibility of common pathophysiological processes.10 Since the influence of systemic diseases on periodontal health has long been recognized and well supported by the available literature including, systematic reviews, observational and interventional trials but an evidence base for the influence of periodontal diseases on overall systemic health has recently begun to be established and it needs further exploration to validate these findings.11 Therefore, the purpose of writing this review article is to assess the evolution of periodontal medicine as a constantly evolving field of research in clinical periodontal research and to highlight the importance of prevention and treatment of periodontal diseases as an important part of preventive measures to reduce the deleterious effects of poor periodontal health on systemic health.
A literature search for published articles was carried out using electronic and manual searches. A search of electronic databases, including PUBMED, MEDLINE up to 2020 was made. Key terms used in the search included Oral health, periodontal diseases, pathogenesis of periodontal diseases, Periodontal disease and systemic conditions, Periodontal medicine, future of perio-systemic association.
Understanding periodontal health and systemic health interrelationships
Periodontal disease is an inflammatory disease in which microbial etiologic factors induce a series of host responses that mediate inflammatory events, leading to tissue destruction in susceptible individuals.12 The recent Global Burden of Disease Study (GBD,1990–2010) indicates that, periodontitis is the 6th most prevalent disease worldwide, with an overall prevalence of 11.2%.13 Periodontal lesions are recognised as a reservoir of gram negative bacteria, inflammatory mediators such as pro-inflammatory cytokines and microbial toxins which could enter the bloodstream and leads to bacteremia which have been found to be a risk factor for diabetes mellitus, cardiovascular disease, respiratory disease, rheumatoid arthritis and other systemic conditions.12 Once the bacteremia takes place, focal infection conditions can occur in the blood stream and organs through three pathways, which include metastatic infection from oral cavity due to bacteremia, metastatic injury due to oral microbial toxins and metastatic inflammation due to immunologic injury caused by oral microorganisms.7, 12, 14
Moreover, periodontal disease can also affect the host’s susceptibility to systemic diseases by three different ways as suggested by Page in 1998. These pathways include shared risk factors for periodontal disease as well as for systemic diseases (smoking, stress, aging, race or ethnicity, and gender), subgingival biofilms acting as reservoirs of gram-negative bacteria and periodontium acting as a reservoir of inflammatory mediators (tumor necrosis factor-a, interleukin-1b, and gamma interferon as well as prostaglandin E2), which can enter the blood stream and induce adverse systemic effects.4, 14
Impact of periodontal diseases on systemic conditions
There is progressive evidence that a number of systemic diseases are associated with opportunistic infections in periodontal medicine.15 As a result, there has been a resurgence of interest in oral microbial ecology, mucosal immunity and associations with systemic conditions, such as Cardiovascular disease, stroke, diabetes, pre-term low birth weight babies, respiratory infections, osteoporosis, cancer, rheumatoid arthritis (RA), Alzheimer's disease (AD), gastrointestinal disease and chronic renal diseases.3, 6, 10, 14, 16
Periodontal disease and cardiovascular diseases
Various possible risk factors associated with cardiovascular diseases among which evidence linking chronic infection and inflammation to cardiovascular disease has been accumulating and suggesting that periodontal disease is capable of predisposing individuals to cardiovascular disease. 17 Accumulating evidence suggests that inflammation plays a central role in the pathogenesis of CVD. 18 Periodontitis is an inflammatory disease caused by gram-negative bacteria, which can induce the production of host inflammatory mediators, eventually leading to the breakdown of tooth-supporting tissues. Presence of periodontal pathogens in atheromatous plaque and their association with atherogenesis have been described in literature. These microbes lead to atherogenesis either by direct invasion of the arterial wall or by release of inflammatory mediators with atherogenic effects. Moreover, increased levels of CRP, TNF-α also provide insight into the association of PD with hypertension. and CVD. 19 This suggests that periodontal disease and CVD may share common etiological pathways and that the association between these two diseases is plausible. Even though a number of meta-analyses indicated the association between PD and CVD, the cause-and-effect relationship between them still not with current available evidence.
Pathways to explain link between CVD and periodontal diseases
Periodontal disease and diabetes
DM is metabolic disorder characterized by hyperglycemia due to defective secretion or activity of insulin. The relationship between diabetes and periodontal diseases is not only bidirectional but cyclical also which means that not only diabetes predisposes the individuals to oral disease but also periodontitis once established exacerbates diabetes and worsen the metabolic control. Periodontal pathogens have the ability to invade deep vascular endothelium in relation to the periodontium and further aggravate the microvascular complications associated with the DM by releasing their toxins and metabolic products.20 Various biologically plausible mechanism that explain pathobiology of the interactions to validate a relationship between diabetes mellitus and periodontal disease described in Figure 3.
Increased cytokine production in periodontal diseases contributes to insulin resistance by modifying the insulin receptor substrate-1 via serine phosphorylation, increasing free fatty acids production by altering adipocyte functions, which further alters the pancreatic B-cell function and decreasing endothelial nitric oxide production.14 A study done by Grossi et al. 1998 suggested that periodontal pathogens by releasing their metabolic products and toxins have the ability to increase the insulin resistance and may complicate the severity of diabetes and the degree of metabolic control.21 Moreover, it has also been confirmed that periodontal therapy in patients with diabetes can improve glycemic control (HbA1C reductions of approximately 0.4%).22 Therefore, people with poorly controlled diabetes must be considered at the risk for periodontitis. Early diagnosis and prevention are of fundamental importance to avoid the large scale irreversible damage to periodontal supporting tissues. Furthermore, closer collaboration between medical and dental clinical teams is necessary for joint management of patients with diabetes and periodontal diseases. Although the mechanisms describing the increase risk of periodontal diseases by diabetes have been demonstrated in abundance in various studies but the impact of periodontal disease on glycemic control of the diabetes is still not clear and it needs further studies.
Periodontal disease and adverse pregnancy outcomes
Although adverse pregnancy outcomes are multifactorial in nature in which a complex molecular and biologic interplay between mother and fetus occur but many studies suggest that periodontal infections may be potentially one of the causes of pregnancy complications.9 Studies have shown that periodontal diseases, including gingivitis and periodontitis, affect approximately three out of four pregnant women resulting in preeclampsia, preterm birth ( (PTB, < 37 weeks’ gestation) and low birth weight ( LBW, 2,500 g,).4 Evidence of increased rates of amniotic fluid infection, chorioamnion infection, and chorioamnionitis supports an association between preterm birth or low birth weight and infection during pregnancy.3 Increased levels of gram-negative bacteria associated with progressive periodontal diseases increases in the dental plaque during second trimester of pregnancy and result in production of a variety of bioactive molecules that can directly affect the host. Microbial components such as LPS activate the cells to synthesize and secrete a wide array of molecules, which include IL-1b, TNF-a, IL-6, and PGE2 and matrix metalloproteinases. These molecules may escape into the general circulation and cross the placental barrier, they could augment the physiologic levels of PGE2 and TNF-a in the amniotic fluid and induce premature Labour.16
Biochemical measures of maternal periodontal status and oral microbial burden are associated with preterm birth and low birth weight as important micorganisms associated with mature plaque and progressing periodontitis, Bacteroides forsythus, P. gingivalis, A. actinomycetemcomitans, and Treponema denticola, are detected at higher levels in mothers of preterm low-birth-weight infants.4 Human case-control studies have shown that women who have low-birth-weight infants as consequence of either preterm labor or premature rupture of membranes tend to have more severe periodontal disease than mothers with normal-birth-weight infants. Moreover, a study by jeffcoat et al. 2001 demonstrated that subjects with generalized periodontitis have 5 fold increased risk of preterm birth before 35 weeks of gestation and 7 fold increased risk of delivery before 32 weeks of gestation and also proposed that bacterial infection can lead to increased amniotic prostaglandin production, which in turn results in pre-term labor.23 Furthermore, among the mothers of preterm low-birth weight a significant inverse association between birth weight and GCF PGE2 levels have been suggested in a case control study.4 However, the role of the host’s inflammatory response appears to be the critical determinant of susceptibility and severity. From these studies, it can be inferred that, periodontitis may be a marker for preterm delivery susceptibility as well as a potential risk factor and may serve as a contributor to the morbidity of the condition.
Periodontal disease and respiratory system
COPD is a combination of chronic bronchitis and emphysema and literature has shown that periodontitis increases the risk of developing COPD. Scannapieco et al in 2003 presented a systematic review and concluded that poor oral hygiene and periodontal diseases appears to be associated with nosocomial pneumonia and improved oral hygiene even in high risk patients have the potential to decrease nosocomial pneumonia.24 In addition to this dental plaque in periodontitis patients may provide a surface over which the potential respiratory pathogens (PRPs) might adhere and provide a reservoir of infection. Furthermore, the oral surfaces of subjects at high-risk for pneumonia, may to provide receptors for the adhesion of PRPs and increase the risk of nosocomial pneumonia in such patients.24
Accumulation and activation of neutrophils is the common pathophysiological mechanism in both the diseases. Since COPD shares similar pathogenic mechanisms with periodontal disease therefore, the resulting neutrophil influx leads to the release of oxidative and hydrolytic enzymes that case tissue destruction directly. Moreover, elevated levels of C reactive proteins (CRP), interlukin-8 (IL-8), tumor necrosis factor- (TNF- α), are also confirmed in both the diseases.25
The influence of systemic conditions on the oral health especially on the periodontium has long been recognized and well supported by scientific evidence. However, an evidence base for the impact of periodontal health on overall systemic health has recently begun to be established. This emerging field of periodontal medicine offers new insights into the concept of the oral cavity as one system that is interconnected to whole human body. Although a number of cross- sectional, case-control and longitudinal studies and systematic review of these studies have explained the positive association between poor periodontal health and systemic diseases but further longitudinal studies and intervention trials are needed to further substantiate these findings. Moreover, readdressing the periodontal-systemic association is potentially of great public health significance as periodontal diseases is largely preventable an readily treatable in most of the instances and further provides new opportunities for prevention and improvement in the prognosis of various systemic diseases and conditions.